Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: Blocking interleukin 18 attenuates intestinal damage

Gut

Volumn 50, Issue 6, 2002, Pages 812-820

  Sivakumar, P V ^a   Westrich, G M ^a   Kanaly, S ^a   Garka, K ^a   Born, T L ^a   Derry, J M J ^a   Viney, J L ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CELL PROTEIN; CHEMOKINE; CYTOKINE; DEXTRAN SULFATE; INTERLEUKIN 18; MATRIX METALLOPROTEINASE; MESSENGER RNA; RECOMBINANT INTERLEUKIN 18; RECOMBINANT INTERLEUKIN 18 BINDING PROTEIN; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HISTOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; INTESTINE INJURY; LARGE INTESTINE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RIBONUCLEASE PROTECTION ASSAY; T LYMPHOCYTE; TH1 CELL; WEIGHT REDUCTION;

ANIMALS; COLITIS, ULCERATIVE; CYTOKINES; DEXTRAN SULFATE; FEMALE; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; LYMPH NODES; MESENTERY; MICE; MICE, INBRED C57BL; RNA; UP-REGULATION; WEIGHT LOSS;

EID: 0036103112     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.6.812     Document Type: Article

References (49)

1. Inflammatory bowel disease
2. Insights from mouse models of colitis
3. The role of the interleukin-1/Toll-like receptor superfamily in inflammation and host defence
4. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease
5. Bioactive IL-18 expression is up-regulated in Crohn's disease
6. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
7. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner
8. Cloning of a new cytokine that induces IFN-γ production by T cells
9. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB
10. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family
11. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme
12. Interleukin-18 and interleukin-1 beta: Two cytokine substrates for ICE (caspase-1)
13. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production
14. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
15. Regulation of interferon-gamma production by IL-12 and IL-18
16. Targeted disruption of the MyD88 gene results in loss af IL-1- and IL-18-mediated functian
17. IL-18 regulates IL-1 beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
18. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response
19. Fetal and neonatal NK1.1+ Ly-49-cells can distinguish between major histocompatibility complex class I(hi) and class I(Io) target cells: Evidence for a Ly-49-independent negative signaling receptor
20. Dextran sulfate sodium (DSS) colitis in rats: Clinical, structural, and ultrastructural aspects
21. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice
22. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling
23. Clinicopathologic study of dextran sulfate sodium experimental murine colitis
24. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
25. Evidence of in situ stability of the type IV collagen triple helix in human inflammatory bowel disease using a denaturation specific epitope antibody
26. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease
27. Regulation of matrix metalloproteinases in human intestinal mucosa
28. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease
29. Recent developments in the immunology of inflammatory bowel disease
30. Blockade or endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-α production
31. Neutrlization of IL-18 exerts anti-inflammatory activity in experimental colitis in mice
32. Cytokines and inflammatory bowel disease
33. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
34. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice
35. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis
36. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis
37. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection
38. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice
39. Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice
40. Nitric oxide and inflammatory bowel diseases
41. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice
42. Chemokines in the inflammatory bowel diseases
43. Matrix metalloproteinases: Effectors of development and normal physiology
44. Differential in situ expression of the genes encoding the chemokines MCP-1 and Rantes in human inflammatory bowel disease
45. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop
46. In situ Rantes and interferon-gamma gene expression in pediatric small bowel Crohn's disease
47. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells
48. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: Lack of CC chemokine receptor 5 expression results in a NK1.1 + lymphocyte-associated Th2-type immune response in the intestine
49. Interleukin-1 alpha-dependent regulation of matrix metalloproteinase-9 (MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts